EVELYN CRUZ: Open Payments
NPI 1891422291 · AVON PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 46 payments from 16 companies in 2025. Trend: 2023 $294 · 2024 $100 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 12 | $440 |
| Axsome Therapeutics, Inc. | 6 | $306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $223 |
| Novo Nordisk Inc | 3 | $172 |
| Supernus Pharmaceuticals, Inc. | 8 | $155 |
| INTUITIVE SURGICAL, INC. | 1 | $103 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
Products named: Korlym, Auvelity, CAPLYTA, Qelbree, Ozempic, Da Vinci Surgical System, AUSTEDO XR, Wegovy.
Industry payments across FL — which companies pay providers there.
